Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(29%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
6
86%
Ph phase_2
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
unknown1
Withdrawn1
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (14.3%)
N/A6 (85.7%)

Trials by Status

unknown114%
completed343%
withdrawn114%
recruiting114%
active_not_recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
OTHER
Total Trials
7